Competition timing requires careful consideration of supplement effects on digestion, energy levels, and performance, with some athletes preferring simple approaches while others benefit from comprehensive metabolic support
If there is any hormonal advantage, it would almost certainly be in the context of an individualized protocol involving lifestyle, diet, and evidence-based medical treatment
It is studied in adults with overweight or obesity (BMI 27 or higher in REDEFINE 1) and in adults with type 2 diabetes (REDEFINE 2 and REIMAGINE 2)
Many patients are now asking what comes next after GLP-1 and dual agonist therapies plateau
Step therapy is common, with Anthem often requiring failure on at least one preferred agent before approving the requested medication
For investors, this means the GLP-1 space isnt a trade on a single company anymore its an ecosystem, with value distributed across innovators, generic challengers, CDMO manufacturers, API suppliers, device makers, and the distribution infrastructure connecting all of them